Marquette Asset Management’s MaxCyte MXCT Stock Holding History

Marquette Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-285,507	Closed	-$351K	–	865
2026 Q2	$351K	Buy	+285,507	New	+$285K	0.05%	64

Other funds holding MXCT

KWMG LLC Overland Park, Kansas $1.39B AUM 24.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Marquette Asset Management's MXCT Position: Q3 2026 in Review

Marquette Asset Management sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 285,507 shares — an estimated $351K sold.

Marquette Asset Management first reported a position in MXCT in Q2 2026 and held it in 1 quarter. The position peaked at $351K in Q2 2026. 4 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

Marquette Asset Management reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
Marquette Asset Management sold 285,507 MaxCyte shares in Q3 2026, an estimated $351K.
Marquette Asset Management first reported a position in MaxCyte in Q2 2026 and held it in 1 quarter.
Marquette Asset Management's MaxCyte position peaked at $351K in Q2 2026.
4 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.